Drug intelligence / Profile preview

nitrofurantoin

Development stage
Approved
Lead developer
Procter & Gamble
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Nitrofurantoin is a nitrofuran antibiotic used primarily to treat uncomplicated urinary tract infections. It works by being rapidly reduced inside bacterial cells by flavoproteins (nitrofuran reductase) to multiple reactive intermediates that damage bacterial DNA and attack ribosomal proteins, respiration pathways, pyruvate metabolism, and other macromolecules. This multi-targeted mechanism inhibits several biochemical and synthetic processes in the bacterial cell and contributes to its low rate of acquired resistance. Nitrofurantoin is concentrated in the urine after oral administration, making it especially effective for lower urinary tract infections but not for kidney infections[1][5][6][8]. The drug was first approved in 1953.

Brand names
MacrobidMacrodantinFuradantinNitro Macro
Other names
nitrofurantoin
02

Targets

MRP (Multidrug resistance-associated protein family)NTR (Bacterial nitroreductase)NeuraminidasePFOR (Pyruvate:ferredoxin oxidoreductase)

Beyond the preview

Go deeper on nitrofurantoin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nitrofurantoin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call